From: Osteomalacia and vitamin D deficiency in a psychiatric rehabilitation unit: case report and survey
Regime | Approximate daily dose | Comments and disadvantages |
---|---|---|
Treatment of vitamin D deficiency | Â | Â |
ergocalciferol 250 μg (10,000 IU) once daily | 10,000 IU vitamin D | Supply problem in the UK. |
ergocalciferol 1.25 mg (50,000 IU) once weekly | 7,000 IU vitamin D | Supply problem in the UK. |
intramuscular ergocalciferol or colecalciferol 7.5 mg (300,000 IU) monthly | 10,000 IU vitamin D | Injection may be unpopular. Supply problem in the UK. |
paediatric ergocalciferol solution (3,000 IU/ml), 3 ml daily | 9,000 IU vitamin D | Special supply arrangements may be required. Excipients may include peanut oil. |
colecalciferol 500 μg (20,000 IU) 3–4 times per week | 8,600–11,400 IU vitamin D | Available from overseas suppliers. |
colecalciferol liquid, e.g. 2,000 IU/ml, 5 ml daily | 10,000 IU vitamin D | Custom strengths available as 'special' orders in the UK. |
commercial 'high strength' (25 μg; 1,000 IU) colecalciferol, two tablets twice daily | 4,000 IU vitamin D | Available from high street health food suppliers including online. |
colecalciferol 25 μg (1,000 IU), two tablets twice daily, plus compound calcium (500 mg) with ergocalciferol or colecalciferol (400 IU), one tablet twice daily | 4,800 IU vitamin D 1,000 mg calcium | Includes sufficient calcium to ensure adequate total intake (though calcium supplements may have low palatability). |
compound calcium (500 mg) with ergocalciferol or colecalciferol (400 IU), two tablets twice daily, plus generic multivitamins (including 300 IU vitamin D), two capsules twice daily | 2,800 IU vitamin D 2,000 mg calcium 10,000 IU vitamin A (3,000 μg RE) 60 mg ascorbic acid 30 mg nicotinamide 2 mg riboflavin 4 mg thiamine | Not ideal. Vitamin D dose lower than recommended treatment regimens. Many tablets required. Calcium content gives poor palatability and may cause gastrointestinal side effects in a few patients [37]. The vitamin A dose may be close to a prudent threshold for teratogenicity, and exceeds the maximum dose recommended for long-term use (1,500 μg RE/day); higher doses are associated with increased risk of hip fracture [37]. No other component is likely to produce toxicity at this dose [37]. |
1-hydroxylated derivatives of vitamin D (e.g. alfacalcidol, dihydrotachysterol, calcitriol) | -- | Not recommended. Does not treat vitamin D deficiency. Higher potential for toxicity. Greater need for monitoring. Few reasons to use, unless severe renal disease or hypocalcaemia [31–34]. |
Maintenance supplementation (examples) | Â | Â |
ergocalciferol 1.25 mg (50,000 IU) every 2–4 weeks or monthly | 1,640–3,570 IU vitamin D | Supply problem in the UK. |
colecalciferol 25 μg (1,000 IU) daily | 1,000 IU vitamin D | -- |
compound calcium (500 mg) with ergocalciferol or colecalciferol (400 IU), one tablet twice daily | 800 IU vitamin D 1,000 mg calcium | Includes sufficient calcium to ensure adequate total intake. |
Additional non-pharmacological options | Â | Â |
sunlight exposure (0.5 minimal erythemal dose daily, e.g. 5–10 minutes of exposure of arms and legs to direct sunlight) | 3,000 IU vitamin D [1] | Excessive exposure predisposes to skin cancer. Latitude, season, time of day and weather alter incoming radiation dose; age and skin pigment alter efficacy. |
cod liver oil (5 ml/day) | 400–1,000 IU vitamin D [1] 2,400–15,600 IU vitamin A (720–4,700 μg RE) [38] other constituents including Ω-3 fatty acids | Caution advised in asthma and pregnancy and in patients on warfarin [39]. May convey other health benefits. Some preparations can contain high doses of vitamin A, which may be disadvantageous (see above). |
oily fish (two portions of 100 g per week) | 70–285 IU vitamin D [1] other constituents including Ω-3 fatty acids | May convey other health benefits. |